L&C Bio (290650.KQ)

L&C Bio stock price today, ATLAS forecast and fair value

Healthcare · Medical Devices · KOSDAQ · South Korea

₩24,900▼ -58.50%

Prices as of Oct 26, 2026 · KRW

ATLAS fair value

ATLAS has no fair value for this stock today.

Chance of rising in 1 month

45%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on L&C Bio in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On L&C Bio

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS's model gives L&C Bio a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between ₩20,839 and ₩28,220; in 9 out of 10, between ₩15,928 and ₩36,920. Estimated annual volatility is 93%.

Price, last 12 months (weekly close)

Key numbers

Market cap: ₩1.5T
Market cap (USD): $1.2B
Dividend yield: 0.08%
52-week high: ₩125,000
52-week low: ₩24,900
Revenue (12 months): ₩116B
Gross margin: 58.7%
Operating margin: 22.1%
Net margin: -128.5%
Beta: 1.51

What this means

ATLAS does not publish a fair value for 290650.KQ right now, but it does show its odds of rising: close to a coin flip.

Over the last 52 weeks 290650.KQ has traded between ₩24,900 and ₩125,000. Today it is 80.1% below that high and 0% above its low.

Its beta is 1.51: it tends to move more than the market, both up and down.

About the company

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Want to see everything about L&C Bio?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What does L&C Bio do?

What is the chance 290650.KQ goes up next month?

45%: close to a coin flip. In half of the simulated outcomes, 290650.KQ ends the month between ₩20,839 and ₩28,220.

How big is L&C Bio and what is its P/E ratio?

L&C Bio's market capitalization is ₩1.5T. We do not show a P/E because it has no positive earnings to base one on.

Does L&C Bio pay a dividend?

Yes. 290650.KQ's current dividend yield is 0.08% at today's price (₩24,900).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer